Sutro Biopharma logo

Sutro Biopharma Share Price (NASDAQ: STRO)

$0.88

0.03

(3.53%)

Live

Last updated on

Check the interactive Sutro Biopharma Stock chart to analyse performance

Sutro Biopharma stock performance

as on August 23, 2025 at 12:37 AM IST

  • Today's Low:$0.85
    Today's High:$0.88

    Day's Volatility :3.59%

  • 52 Weeks Low:$0.52
    52 Weeks High:$5.17

    52 Weeks Volatility :89.88%

Sutro Biopharma Stock Returns

PeriodSutro Biopharma IncSector (Health Care)Index (Russel 2000)
3 Months
-7.61%
5.0%
0.0%
6 Months
-51.98%
-6.4%
0.0%
1 Year
-81.32%
-11.5%
0.0%
3 Years
-85.97%
4.5%
-7.7%

Sutro Biopharma Inc Key Stats

Check Sutro Biopharma key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.85
Open
$0.8451
Today's High
$0.8622
Today's Low
$0.8429
Market Capitalization
$71.9M
Today's Volume
$217.3K
52 Week High
$5.17
52 Week Low
$0.5231
Revenue TTM
$104.5M
EBITDA
$-158.1M
Earnings Per Share (EPS)
$-2.51
Profit Margin
-199.76%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-347.64%

Stock Returns calculator for Sutro Biopharma Stock including INR - Dollar returns

The Sutro Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Sutro Biopharma investment value today

Current value as on today

₹23,595

Returns

₹76,405

(-76.4%)

Returns from Sutro Biopharma Stock

₹80,659 (-80.66%)

Dollar Returns*

₹4,255 (+4.25%)

Indian investors sentiment towards Sutro Biopharma Stock

-36%

Period: Jul 22, 2025 to Aug 21, 2025. Change in 30 Days versus previous period

Search interest for Sutro Biopharma Stock from India on INDmoney has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Sutro Biopharma Inc

  • Name

    Holdings %

  • Suvretta Capital Management, LLC

    8.81%

  • BlackRock Inc

    7.32%

  • Kynam Capital Management, LP

    6.01%

  • RA Capital Management, LLC

    5.23%

  • Vanguard Group Inc

    4.86%

  • Acadian Asset Management LLC

    3.70%

Analyst Recommendation on Sutro Biopharma Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 16 Wall street analysts offering stock ratings for Sutro Biopharma(by analysts ranked 0 to 5 stars)

Sutro Biopharma Share Price Target

What analysts predicted

Upside of 253.9%

Target:

$3.11

Current:

$0.88

Sutro Biopharma share price target is $3.11, a slight Upside of 253.9% compared to current price of $0.88 as per analysts' prediction.

Sutro Biopharma Stock Insights

  • Price Movement

    In the last 6 months, STRO stock has moved down by -52.0%
  • Increasing Revenue

    Revenue is up for the last 4 quarters, 8.52M → 63.74M (in $), with an average increase of 43.4% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -75.96M → -11.49M (in $), with an average increase of 560.7% per quarter
  • STRO vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.3% return, outperforming this stock by 149.6%
  • STRO vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 114.2% return, outperforming this stock by 200.2%
  • Price to Sales

    ForSTRO every $1 of sales, investors are willing to pay $0.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $24.6 for every $1 of sales.

Sutro Biopharma Inc Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$62.0M
↓ 59.64%
Net Income
$-227.5M
↑ 112.99%
Net Profit Margin
-366.62%
↓ 297.15%

Sutro Biopharma Technicals Summary

Sell

Neutral

Buy

Sutro Biopharma is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Sutro Biopharma Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Sutro Biopharma Inc logo
-1.67%
-51.98%
-81.32%
-85.97%
-90.42%
Regeneron Pharmaceuticals, Inc. logo
4.5%
-14.59%
-49.64%
-0.73%
0.56%
Beone Medicines Ltd logo
6.48%
22.93%
60.47%
81.44%
32.24%
Vertex Pharmaceuticals Incorporated logo
-16.69%
-17.94%
-17.2%
38.81%
48.58%
Alnylam Pharmaceuticals, Inc. logo
43.34%
86.27%
68.31%
115.22%
254.29%

About Sutro Biopharma Inc

Sutro Biopharma, Inc. operates as a oncology company. The company develops site-specific and novel-format antibody drug conjugates (ADCs) that enables its proprietary integrated cell-free protein synthesis platform, XpressCF; and site-specific conjugation platform, XpressCF+. Its lead product candidate includes STRO-004, a tissue factor (TF) targeting ADC for the treatment of TF-expressing solid tumors, including cervical, lung, and breast cancer. The company also develops VAX-24 and Vax-31 pneumococcal conjugate vaccine candidates that is in Phase II/III clinical trials for the treatment of invasive pneumococcal disease; and STRO-003, an ADC directed against an anti-receptor tyrosine kinase-like orphan receptor 1 (ROR1) for the treatment of solid tumors, such as triple negative breast cancer, non-small cell lung cancer, and ovarian cancer, as well as hematological cancers. Sutro Biopharma, Inc. has collaboration and license agreements with Vaxcyte to discover and develop vaccine candidates for the treatment or prophylaxis of infectious diseases; Tasly Biopharmaceuticals Co., Ltd. to develop and commercialize STRO-002 in Greater China; Ipsen to develop and commercialize STRO-003, an ADC targeting ROR1; and Astellas Pharma Inc. to develop immunostimulatory ADC. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.
Organization
Sutro Biopharma
Employees
244
CEO
Ms. Jane Chung R.Ph.
Industry
Health Technology

Key Management of Sutro Biopharma Inc

NameTitle
Ms. Jane Chung R.Ph.
CEO & Director
Mr. Edward C. Albini M.B.A
Secretary
Dr. James R. Swartz DSc, Ph.D., Sc.D.
Founder
Mr. Gregory K. Chow BA, CPA, MBA
Chief Financial Officer
Dr. Venkatesh Srinivasan Ph.d.
Chief Technical Operations Officer
Dr. Hans-Peter Gerber Ph.D.
Chief Scientific Officer
Mr. David Pauling J.D., M.A.
Chief Administrative Officer & General Counsel
Dr. Barbara Leyman Ph.D.
Chief Business Officer
Ms. Regina Cheng
Vice President & Controller

Important FAQs about investing in STRO Stock from India :

What is Sutro Biopharma share price today?

Sutro Biopharma share price today is $0.88 as on . Sutro Biopharma share today touched a day high of $0.88 and a low of $0.85.

What is the 52 week high and 52 week low for Sutro Biopharma share?

Sutro Biopharma share touched a 52 week high of $5.17 and a 52 week low of $0.52. Sutro Biopharma stock price today i.e. is trending at $0.88, lower by 82.98% versus the 52 week high.

How to invest in Sutro Biopharma Stock (STRO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Sutro Biopharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sutro Biopharma Shares that will get you 1.7045 shares as per Sutro Biopharma share price of $0.88 per share as on August 23, 2025 at 12:37 AM IST.

What is the minimum amount required to buy Sutro Biopharma Stock (STRO) from India?

Indian investors can start investing in Sutro Biopharma (STRO) shares with as little as ₹87.499 or $1 (as of August 22, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹874.99 in Sutro Biopharma stock (as per the Rupee-Dollar exchange rate as on August 22, 2025). Based on Sutro Biopharma share’s latest price of $0.88 as on August 23, 2025 at 12:37 AM IST, you will get 11.3636 shares of Sutro Biopharma. Learn more about fractional shares .

What are the returns that Sutro Biopharma has given to Indian investors in the last 5 years?

Sutro Biopharma stock has given -90.42% share price returns and 17.97% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?